Baker Bros. Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,753
| Closed | -$3.27M | – | 120 |
|
|
2018
Q2 | $3.27M | Hold |
3,753
| – | – | 0.02% | 89 |
|
|
2018
Q1 | $4.72M | Hold |
3,753
| – | – | 0.04% | 77 |
|
|
2017
Q4 | $5.61M | Hold |
3,753
| – | – | 0.05% | 74 |
|
|
2017
Q3 | $7.68M | Buy |
3,753
+2,353
| +168% | +$4.82M | 0.06% | 61 |
|
|
2017
Q2 | $3.67M | Hold |
1,400
| – | – | 0.03% | 70 |
|
|
2017
Q1 | $4.2M | Hold |
1,400
| – | – | 0.03% | 69 |
|
|
2016
Q4 | $2.09M | Hold |
1,400
| – | – | 0.02% | 92 |
|
|
2016
Q3 | $2.47M | Hold |
1,400
| – | – | 0.02% | 90 |
|
|
2016
Q2 | $2.63M | Hold |
1,400
| – | – | 0.03% | 86 |
|
|
2016
Q1 | $3.14M | Hold |
1,400
| – | – | 0.03% | 86 |
|
|
2015
Q4 | $3.37M | Hold |
1,400
| – | – | 0.03% | 91 |
|
|
2015
Q3 | $3.33M | Buy |
+1,400
| New | +$3.33M | 0.03% | 87 |
|